Get started
Author

Yaye Wang

Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study
2023 · Jingsi Wang, Hongyu Zhou, et al. · QJM · 11
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis
2025 · Shu Zhang, Qi Wen, et al. · Journal of Autoimmunity · 10
Platelet activation plays a pro-inflammatory role in myasthenia gravis
2025 · Qi Wen, Shu Zhang, et al. · Nature Communications · 8
PDF
Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients
2025 · Nairong Xie, Qing Liu, et al. · Therapeutic Advances in Neurological Disorders · 8
Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study
2025 · Wenjia Zhu, Yuping Chen, et al. · Journal of Neurology · 7
PDF
Case report: Meningoencephalocele and recurrent bacterial meningitis in chronic idiopathic intracranial hypertension
2022 · Jinru Zhang, Jianchao Wu, et al. · BMC Neurology · 5
PDF
A rare complex structural variant of novel intragenic inversion combined with reciprocal translocation t(X;1)(p21.2;p13.3) in Duchenne muscular dystrophy
2024 · Yaye Wang, Xinmei Wen, et al. · Neuromuscular Disorders · 4
A synonymous codon variant altering splicing of RBCK1 expands the phenotype and genotype spectra of polyglucosan body myopathy 1
2023 · Qi Wen, Wenjia Zhu, et al. · Clinical Genetics · 4
PDF
Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia Gravis
2025 · Yaye Wang, Wenjia Zhu, et al. · CNS Neuroscience & Therapeutics · 3
PDF
The Impact of COVID-19 Vaccination and Infection on the Exacerbation of Myasthenia Gravis
2024 · Yuting Jiang, Jingsi Wang, et al. · Vaccines · 2
Tacrolimus as Single‐Agent Immunotherapy for Adult‐Onset Myasthenia Gravis: Remission, Relapse, and Safety
2026 · Zhangyan Geng, Yuting Jiang, et al. · CNS Neuroscience & Therapeutics · 1
Cerebrospinal fluid inflammatory proteomic profiling identifies biomarkers linked to disease progression in amyotrophic lateral sclerosis
2026 · Congwen Lv, Wenjia Zhu, et al. · Journal of Neurology
Comparative efficacy of single-cycle intravenous efgartigimod versus intravenous immunoglobulin in generalized myasthenia gravis patients receiving concomitant immunosuppressive therapy
2026 · Haoran Liu, Xinmei Wen, et al. · Neuromuscular Disorders
Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross‐Sectional Study
2026 · Haoran Liu, Jingsi Wang, et al. · CNS Neuroscience & Therapeutics
PDF
Works count: 14
Citation count: 63
H-index: 5
I10-index: 2
Year
Topic
Type